Apella, founded in 2020, is at the forefront of revolutionizing healthcare with its innovative approach towards surgery. The company's slogan, "Technology for better surgery," encapsulates its mission to enhance surgical outcomes using advanced technologies.
Specializing in the integration of artificial intelligence, computer vision, and modern communications, Apella is positioned within several key industries, including AI, Health Care, Health and Wellness, and Machine Learning. Its headquarters are based in the United States, reflecting its global ambition in the healthcare technology space.
The company successfully raised a $21.00M Series A investment on 20 December 2021. This funding round was supported by prominent investors such as Casdin Capital, Upside Partnership, Operator Partners, Vensana Capital, Twine Ventures, and PFM Health Sciences, showcasing strong confidence in Apella's potential to transform surgery.